These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2808212)

  • 1. The disposition and metabolism of meropenem in laboratory animals and man.
    Harrison MP; Moss SR; Featherstone A; Fowkes AG; Sanders AM; Case DE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():265-77. PubMed ID: 2808212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and metabolic fate of 14C-meropenem in man.
    Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
    Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of prinomide in laboratory animals.
    Egger H; Itterly W; John V; Rodebaugh R; Shimanskas C; Stancato F; Kapoor A
    Drug Metab Dispos; 1988; 16(4):568-75. PubMed ID: 2903025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.
    Wong BK; Sahly Y; Mistry G; Waldman S; Musson D; Majumdar A; Xu X; Yu S; Lin JH; Singh R; Holland S
    Xenobiotica; 2004 Apr; 34(4):379-89. PubMed ID: 15268982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkey.
    Pue MA; Ransley JA; Writer DJ; Dean AJ; Franklin ER; Beattie IG; Ross DA
    Eur J Drug Metab Pharmacokinet; 1989; 14(3):209-19. PubMed ID: 2612518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
    Ando T; Momota K; Sugiyama M
    Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.
    Chadwick M; Silveira DM; MacGregor JA; Branfman AR; Liss RH; Yesair DW
    Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of meropenem in volunteers.
    Bax RP; Bastain W; Featherstone A; Wilkinson DM; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():311-20. PubMed ID: 2808215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
    Tse FL; Orwig B; Jaffe JM
    Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals].
    Kijima K; Morita J; Suzuki K; Aoki M; Kato K; Hayashi H; Shibasaki S; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):214-40. PubMed ID: 19882982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals.
    Shibayama T; Matsushita Y; Kawai K; Hirota T; Ikeda T; Kuwahara S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):257-63. PubMed ID: 17074792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man.
    Scatina JA; Hicks DR; Kraml M; Cayen MN
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):37-48. PubMed ID: 2384116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
    Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.